The RNAi therapeutics and technologies market is anticipated to grow at a CAGR of 20%, till 2035, claims Roots Analysis
24. August 2022 12:38 ET
|
Roots Analysis
London, Aug. 24, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “RNAi Therapeutics Market, 2022-2035” report to its list of offerings. Over time, significant strides have...
MDRNA, Inc. Appoints James M. Karis to Its Board of Directors
11. August 2009 09:15 ET
|
MDRNA, Inc.
BOTHELL, WA--(Marketwire - August 11, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that
James M. Karis has been appointed to the Company's Board of Directors. His
appointment brings the number...